Biote Corp. is a medical - care facilities company in the healthcare sector trading on NASDAQ, led by CEO Bret Christensen, with a market cap of $40.5M.
Upcoming earnings announcement for Biote Corp.
Past 12 earnings reports for Biote Corp.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 11, 2026 | Q4 2025 | $0.06Est: $0.08 | -25.0% | $46.4MEst: $45.8M | +1.4% | |
| Nov 5, 2025 | Q3 2025 | $0.22Est: $0.09 | +144.4% | $48.0MEst: $47.7M | +0.5% | |
| Aug 6, 2025 | Q2 2025 | $0.10Est: $0.10 | 0.0% | $48.9MEst: $49.5M | -1.3% | |
| May 7, 2025 | Q1 2025 | $0.37Est: $0.13 | +184.6% | $49.0MEst: $47.3M | +3.7% | |
| Mar 12, 2025 | Q4 2024 | $0.10Est: $0.17 | -41.2% | $49.8MEst: $51.2M | -2.7% | |
| Nov 12, 2024 | Q3 2024 | $0.33Est: $0.09 | +266.7% | $51.4MEst: $51.4M | +0.0% | |
| Aug 8, 2024 | Q2 2024 | -$0.19Est: $0.09 | -311.1% | $49.2MEst: $49.1M | +0.2% | |
| May 7, 2024 | Q1 2024 | -$0.06Est: $0.03 | -300.0% | $46.8MEst: $45.7M | +2.4% | |
| Mar 12, 2024 | Q4 2023 | $0.18Est: $0.08 | +125.0% | $45.7MEst: $45.7M | -0.1% | |
| Nov 7, 2023 | Q3 2023 | $0.24Est: $0.07 | +242.9% | $45.6MEst: $47.9M | -4.9% | — |
| Aug 10, 2023 | Q2 2023 | -$0.25Est: $0.09 | -377.8% | $49.3MEst: $46.8M | +5.3% | |
| May 9, 2023 | Q1 2023 | -$0.39Est: $0.09 | -533.3% | $44.8MEst: $43.5M | +3.2% | — |
We use cookies for analytics. See our Privacy and Cookie Policy.